Sarda Proteins Ltd Financials

Sarda Proteins Ltd Financial Statement

Sarda Proteins Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Sep 2024	Jun 2024	Mar 2024
Revenue	0.14	TBA	0.10
Operating Expense	0.04	0.08	0.08
Net Profit	0.10	-0.08	0.02
Net Profit Margin	71.43	TBA	20
Earning Per Share	0.61	-0.46	0.12
EBIDTA	0.10	-0.08	0.02
Effective Tax Rate	TBA	TBA	TBA

Particulars	Sep 2024
Revenue	0.14
Operating Expense	0.04
Net Profit	0.10
Net Profit Margin	71.43
Earning Per Share	0.61
EBIDTA	0.10
Effective Tax Rate	TBA

Sarda Proteins Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Total Revenue Annual	1.30	5.80	10.76
Operating Expenses Annual	1.44	5.94	10.49
Operating Profit Annual	0.02	0.01	0.35
Interest Annual	0.00	TBA	0.00
Depreciation	TBA	TBA	0.00
Net Profit Annual	0.02	-0.03	0.31
Tax Annual	-0.00	0.05	0.05

Particulars	Mar 2024
Total Revenue Annual	1.30
Operating Expenses Annual	1.44
Operating Profit Annual	0.02
Interest Annual	0.00
Depreciation	TBA
Net Profit Annual	0.02
Tax Annual	-0.00

Sarda Proteins Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Cash Flow at the Beginning	0.18	0.33	0.13
Cash Flow from Operations	-0.23	-0.30	0.10
Cash Flow from Investing	0.17	0.16	0.09
Cash Flow from Financing	TBA	TBA	TBA
Cash Flow at the End	0.12	0.18	0.33

Particulars	Mar 2024
Cash Flow at the Beginning	0.18
Cash Flow from Operations	-0.23
Cash Flow from Investing	0.17
Cash Flow from Financing	TBA
Cash Flow at the End	0.12

Sarda Proteins Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
PBDIT Margin (%)	1.54	0.17	3.25
PBIT Margin (%)	1.54	0.17	3.25
PBT Margin (%)	1.54	0.17	3.25
Net PROFIT Margin (%)	1.54	-0.52	2.88
Return On Networth / Equity (%)	0.82	TBA	13.57
Return On Networth /Employed (%)	0.81	TBA	15.58
Return On Assets (%)	0.83	-1.25	13.71
Total Debt / Equity (X)	TBA	TBA	TBA
Asset Turnover Ratio (%)	0.54	2.42	4.76

Particulars	Mar 2024
PBDIT Margin (%)	1.54
PBIT Margin (%)	1.54
PBT Margin (%)	1.54
Net PROFIT Margin (%)	1.54
Return On Networth / Equity (%)	0.82
Return On Networth /Employed (%)	0.81
Return On Assets (%)	0.83
Total Debt / Equity (X)	TBA
Asset Turnover Ratio (%)	0.54

Sarda Proteins Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Fixed Assets Annual	0.00	0.00	0.00
Total Current Assets Annual	2.30	2.27	2.27
Non Current Assets Annual	0.14	0.14	0.18
Total Shareholders Funds Annual	2.37	2.35	2.39
Total Assets Annual	2.43	2.40	2.45

Particulars	Mar 2024
Fixed Assets Annual	0.00
Total Current Assets Annual	2.30
Non Current Assets Annual	0.14
Total Shareholders Funds Annual	2.37
Total Assets Annual	2.43

Sarda Proteins Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

Get Your FAQs Right

As of Dec 26, 2024, Sarda Proteins Ltd has a market capitalization of 9.28 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Sarda Proteins Ltd is debt-free with a debt-to-equity ratio of 0.00.

In FY 2023 , Sarda Proteins Ltd recorded a total revenue of approximately 1.30 Cr marking a significant milestone in the company's financial performance.

Sarda Proteins Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.2% and -1.1% annually, respectively..

Sarda Proteins Ltd's current PE ratio is 464.00.

Sarda Proteins Ltd's ROCE averaged 5.4% from the FY ending March 2022 to 2024, with a median of 0.8%. It peaked at 14.8% in March 2022, reflecting strong capital efficiency over the period..

Sarda Proteins Ltd's latest EBIT is Rs. 0.02 Cr, surpassing the average EBIT of Rs. 0.13 Cr over the 5 years..